Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Feasibility Study of High Surgical Risk Patients With Severe Mitral Regurgitation Treated With the Cardiovalve Transfemoral Mitral Valve System (AHEAD Study)

NCT03339115 is registered in ClinicalTrials.gov with Cardiovalve Ltd. as lead sponsor.

NCT NCT03339115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03339115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Feasibility Study of High Surgical Risk Patients With Severe Mitral Regurgitation Treated With the Cardiovalve Transfemoral Mitral Valve System (AHEAD Study)
Lead sponsor
Cardiovalve Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 23, 2018
Completion date
December 31, 2030
Enrollment
30 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation, mitral valve disease